CBDVA
Limited data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 2 corroborating sources
- duration data present
- 16 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
- 2 corroborating sources
- duration data present
- 16 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
Summary
CBDVA is the carboxylic-acid precursor of cannabidivarin (CBDV); heating or vaping will largely decarboxylate it into CBDV. Pre-clinical data suggest anticonvulsant, anti-inflammatory, and 5-HT1A-mediated anti-nausea properties similar to CBDA, but human data are sparse. Like CBD, CBDVA appears to inhibit CYP3A4, CYP2C19 and CYP2C9, so therapeutic drug monitoring is advised when combined with narrow-therapeutic-index medications (e.g., warfarin, clobazam, tacrolimus).
Dose Information
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 30-90 min | 30-60 min | 2-4 hrs | 2-4 hrs |
| Sublingual | 15-45 min | 20-40 min | 1.5-3 hrs | 1.5-3 hrs |
| Vaporized | 1-5 min | 5-15 min | 10-30 min | 1-2 hrs |
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session — the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Effects
- Anxiolysis
- Reduced inflammation perception
- Anticonvulsant effects
- Mild stimulation at low doses
- Antiemetic effects
- Sedation at higher doses
- Subtle relaxation
- Mild mood elevation
- Increased focus
Combinations
Cross-Check CBDVA with another substanceHelpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for CBDVA? Let us know. Reports are reviewed by moderators — this is not posted publicly.